Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users

The Current Landscape of Cobenfy (KarXT): Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization

This study uses existing health records and insurance claims data to understand how adults in the United States are treated with KarXT, a medication for schizophrenia. It will describe who receives KarXT, how it is used in real-world practice, and how often healthcare services such as hospital visits are used. It will also explore information recorded by clinicians about schizophrenia symptoms

Inclusion Criteria:

• Participants in the Veradigm EHR/claims-linked database with evidence of treatment with KarXT on or after September 24, 2024
• Earliest KarXT treatment date = index date
• Aged 18 years or older on index date

Exclusion Criteria:

• Not applicable